- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06705920
Effect of Topical Active Oxygen Therapy on Surgical Site Wound Healing and Microbial Colonization
November 23, 2024 updated by: ahmed hamdy mahmoud, Ain Shams University
Effect of Topical Active Oxygen Therapy on Surgical Site Wound Healing and Microbial Colonization : Randomized Controlled Clinical Trial
To assess the antibacterial efficiency of oxygenated gel therapy on wound healing and microbiological colonization around surgical sutures
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
All the patients who will agree to participate in the study and who will sign the informed consent forms.
Computer-generated randomization will be used to randomly divide the surgical sites into two groups.
Control group: will receive no treatment.
Study group: will receive active oxygen gel around suture.
Patients scheduled for any oral surgical flap procedure that require suturing will be included in this study.
After flap approximation, the surgical site will be sutured using 5-0 braided sutures.
In the study group the gel will be applied over the suture and the patients will be instructed to apply the gel to the wound area and to the suture thread using a cotton swab, three times a day after brushing their teeth.
Also, patients will be given instructions regarding their post-surgical care.
Study Type
Interventional
Enrollment (Estimated)
44
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo
-
Al Sherouk, Cairo, Egypt, 11837
- Faculty of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult patients in a healthy systemic condition who required comprehensive dental treatment
- Both genders with age group > 18 years old
- Patients should approve to deliver a signature to a written consent after study nature explanation.
Exclusion Criteria:
- Patients with severe smoking habits >10 cig \ day
- Pregnant females, decisional impaired individuals and handicapped patients
- Patients having poor oral hygiene or not wanting to carry out oral hygiene measures
- Patients on any medication affecting the soft tissue health (e.g., amlodipine, Cyclosporine A, hydantoin)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control
patient who will undergo intraoral surgical procedures , will have his wound sutured without any addtives
|
|
|
Active Comparator: test
patient who will undergo intraoral surgical procedures , will have his wound sutured with the addition of blue m gel twice daily
|
In the study group the gel will be applied over the suture and the patients will be instructed to apply the gel to the wound area and to the suture thread using a cotton swab
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post operative wound healing.
Time Frame: 2 weeks
|
Wound healing will be recorded in the 1st and 2 weeks postoperatively through Landry Wound Healing Index (LWHI) which evaluates the surgical site based on tissue color, response to touch, the marginality of the incision line, and extent of the area.
The rating is from 1 = very poor to 5 = excellent.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbiological assessment
Time Frame: 2 weeks
|
The collected samples of suture thread will be immersed in phosphate-buffered saline solution (PBS) immediately after their removal and This sample will be subsequently sent to the microbiology laboratory of the Faculty of Pharmacy of the British university in Egypt.
The samples will be shaken vigorously for two minutes to separate the bacteria from the suture thread, and to obtain a homogeneous suspension.
serial dilutions in saline will be subsequently prepared.
50 microliters of each dilution will be plated in Petri dishes containing different culture media.The blood agar, mannitol agar, MacConkey agar, and Sabouraud agar plates will be aerobically incubated at 37 °C for 24-48 hours.
After incubation, the colony forming units (CFUs) will be counted and the total number of CFUs per milliliter of initial solution will be calculated
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2024
Primary Completion (Estimated)
March 1, 2025
Study Completion (Estimated)
June 1, 2025
Study Registration Dates
First Submitted
November 23, 2024
First Submitted That Met QC Criteria
November 23, 2024
First Posted (Estimated)
November 26, 2024
Study Record Updates
Last Update Posted (Estimated)
November 26, 2024
Last Update Submitted That Met QC Criteria
November 23, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-042
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on topical oxygen gel
-
Novan, Inc.CompletedAcne VulgarisUnited States
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Rhodes Pharmaceuticals, L.P.ORA, Inc.Completed
-
Cairo UniversityNot yet recruitingChild | Gag ReflexEgypt
-
Maruho Co., Ltd.Leiden University Medical CenterCompletedCondylomata Acuminata (External)Netherlands
-
Fisher and Paykel HealthcareRecruiting
-
Novan, Inc.CompletedAcne VulgarisUnited States
-
AOTI Ltd.Terminated
-
Lakewood-Amedex IncPrimeVigilance; Professional Education and Research InstituteTerminated
-
Maruho Co., Ltd.CompletedUsual Type Vulval Intraepithelial Neoplasia (uVIN)Netherlands